Effectiveness and impact of universal prophylaxis with nirsevimab in infants against hospitalisation for respiratory syncytial virus in Galicia, Spain: initial results of a population-based longitudinal study

  1. Ares-Gómez, S.
  2. Mallah, N.
  3. Santiago-Pérez, M.-I.
  4. Pardo-Seco, J.
  5. Pérez-Martínez, O.
  6. Otero-Barrós, M.-T.
  7. Suárez-Gaiche, N.
  8. Kramer, R.
  9. Jin, J.
  10. Platero-Alonso, L.
  11. Alvárez-Gil, R.-M.
  12. Ces-Ozores, O.-M.
  13. Nartallo-Penas, V.
  14. Mirás-Carballal, S.
  15. Piñeiro-Sotelo, M.
  16. Malvar-Pintos, A.
  17. González-Pérez, J.-M.
  18. Rodríguez-Tenreiro-Sánchez, C.
  19. Rivero-Calle, I.
  20. Salas, A.
  21. Durán-Parrondo, C.
  22. Martinón-Torres, F.
Revista:
The Lancet Infectious Diseases

ISSN: 1474-4457 1473-3099

Ano de publicación: 2024

Tipo: Artigo

DOI: 10.1016/S1473-3099(24)00215-9 GOOGLE SCHOLAR